Cereseto A - Search Results

1

Base Editors Flex Sights on Sickle-Cell Disease.

Cereseto A, Cradick TJ, Davies K. Cereseto A, et al. CRISPR J. 2021 Apr;4(2):166-168. doi: 10.1089/crispr.2021.29125.kda. CRISPR J. 2021. PMID: 33876950 No abstract available.

2

Mechanism of paclitaxel activity in Kaposi's sarcoma.

Sgadari C, Toschi E, Palladino C, Barillari G, Carlei D, Cereseto A, Ciccolella C, Yarchoan R, Monini P, Stürzl M, Ensoli B. Sgadari C, et al. Among authors: cereseto a. J Immunol. 2000 Jul 1;165(1):509-17. doi: 10.4049/jimmunol.165.1.509. J Immunol. 2000. PMID: 10861090

3

Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines.

Cereseto A, Berneman Z, Koralnik I, Vaughn J, Franchini G, Klotman ME. Cereseto A, et al. Leukemia. 1997 Jun;11(6):866-70. doi: 10.1038/sj.leu.2400665. Leukemia. 1997. PMID: 9177442

4

Cytokine response gene 6 induces p21 and regulates both cell growth and arrest.

Fan W, Richter G, Cereseto A, Beadling C, Smith KA. Fan W, et al. Among authors: cereseto a. Oncogene. 1999 Nov 11;18(47):6573-82. doi: 10.1038/sj.onc.1203054. Oncogene. 1999. PMID: 10597261

5

Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.

Cereseto A, Washington Parks R, Rivadeneira E, Franchini G. Cereseto A, et al. Oncogene. 1999 Apr 15;18(15):2441-50. doi: 10.1038/sj.onc.1202567. Oncogene. 1999. PMID: 10229195

6

Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.

Cereseto A, Mulloy JC, Franchini G. Cereseto A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S69-75. doi: 10.1097/00042560-199600001-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8797707 Review.

7

HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.

Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, Falchi M, Nappi F, Sgadari C, Barillari G, Mainiero F, Ensoli B. Toschi E, et al. Among authors: cereseto a. Mol Biol Cell. 2006 Apr;17(4):1985-94. doi: 10.1091/mbc.e05-08-0717. Epub 2006 Jan 25. Mol Biol Cell. 2006. PMID: 16436505 Free PMC article.

8

HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.

Nicot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, Brady JN, Franchini G. Nicot C, et al. Among authors: cereseto a. Oncogene. 2000 Apr 20;19(17):2155-64. doi: 10.1038/sj.onc.1203536. Oncogene. 2000. PMID: 10815807

9

A highly specific SpCas9 variant is identified by in vivo screening in yeast.

Casini A, Olivieri M, Petris G, Montagna C, Reginato G, Maule G, Lorenzin F, Prandi D, Romanel A, Demichelis F, Inga A, Cereseto A. Casini A, et al. Among authors: cereseto a. Nat Biotechnol. 2018 Mar;36(3):265-271. doi: 10.1038/nbt.4066. Epub 2018 Jan 29. Nat Biotechnol. 2018. PMID: 29431739 Free PMC article.

10

Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.

Maule G, Arosio D, Cereseto A. Maule G, et al. Among authors: cereseto a. Int J Mol Sci. 2020 May 30;21(11):3903. doi: 10.3390/ijms21113903. Int J Mol Sci. 2020. PMID: 32486152 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page